Kyungdong Pharm banner
K

Kyungdong Pharm
KOSDAQ:011040

Watchlist Manager
Kyungdong Pharm
KOSDAQ:011040
Watchlist
Price: 5 360 KRW Market Closed
Market Cap: ₩164.9B

Balance Sheet

Balance Sheet Decomposition
Kyungdong Pharm

Balance Sheet
Kyungdong Pharm

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
6 300
3 756
6 067
37 767
30 337
21 294
25 912
12 629
12 804
18 223
23 955
15 693
22 011
18 992
18 076
22 909
25 130
30 130
62 953
15 992
17 807
14 553
11 779
15 769
Cash
0
0
0
0
0
0
0
0
0
0
0
0
4 079
4 338
3 875
4 742
4 227
4 123
14
13
1
3
2
1
Cash Equivalents
6 300
3 756
6 067
37 767
30 337
21 294
25 912
12 629
12 804
18 223
23 955
15 693
17 932
14 654
14 201
18 167
20 903
26 007
62 939
15 979
17 807
14 550
11 777
15 768
Short-Term Investments
19 737
23 782
35 628
16 498
36 991
37 293
35 094
40 736
32 670
31 045
38 707
46 709
41 000
33 000
19 000
41 600
28 000
53 787
32 054
45 356
32 236
30 575
20 295
15 144
Total Receivables
22 773
21 829
15 257
16 140
17 258
15 543
11 148
11 125
16 962
16 578
19 394
15 169
12 984
19 080
14 283
15 928
22 516
14 989
20 241
18 643
21 508
25 485
20 664
24 335
Accounts Receivables
22 277
21 420
14 798
15 223
17 230
15 533
11 131
11 123
16 788
16 314
17 234
13 897
12 724
15 398
13 991
15 810
21 717
14 835
20 120
18 151
21 288
25 374
20 245
24 052
Other Receivables
496
409
459
917
28
10
17
2
174
264
2 160
1 272
260
3 682
292
118
799
154
121
491
220
111
418
283
Inventory
4 839
5 663
5 972
8 963
10 773
11 318
12 596
13 445
14 805
15 917
16 214
20 509
25 298
26 622
23 135
23 873
28 195
26 471
25 105
28 926
29 770
30 158
34 535
44 447
Other Current Assets
15
7
8
8
43
46
28
247
15
1 049
737
1 201
4 465
5 046
11 114
8 171
6 286
774
1 959
838
1 887
2 210
2 476
2 134
Total Current Assets
53 664
55 037
62 932
79 376
95 402
85 493
84 778
78 183
77 257
82 813
99 007
99 282
105 759
102 741
85 607
112 480
110 127
126 152
142 312
109 755
103 208
102 981
89 749
101 829
PP&E Net
11 379
15 026
16 765
16 895
28 307
32 558
35 498
36 555
71 461
46 293
44 769
47 370
49 989
68 411
73 801
71 250
70 829
67 970
66 513
88 585
89 880
95 097
73 646
74 796
PP&E Gross
11 379
15 026
16 765
16 895
28 307
32 558
35 498
36 555
71 461
46 293
44 769
47 370
49 989
68 411
73 801
71 250
70 829
67 970
66 513
88 585
89 880
95 097
73 646
74 796
Accumulated Depreciation
4 973
6 452
8 309
10 120
11 733
15 440
20 094
24 958
30 084
31 570
35 709
40 426
47 354
46 411
51 538
55 449
59 264
65 652
70 344
74 573
77 565
74 809
77 901
82 437
Intangible Assets
6
8
8
8
16
25
32
41
48
2 673
2 703
2 756
2 674
3 216
3 600
3 576
3 552
3 162
2 460
2 194
2 998
2 889
5 689
8 161
Goodwill
0
0
0
0
0
0
0
0
0
450
450
450
500
500
500
500
450
450
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
1 576
1 693
Long-Term Investments
3 795
3 834
3 742
3 877
622
882
6 574
5 020
7 528
38 431
38 363
39 016
40 134
52 694
69 663
50 372
65 840
58 904
75 469
88 069
93 225
102 002
116 939
111 999
Other Long-Term Assets
942
977
1 084
2 015
3 487
4 220
3 747
3 127
3 665
370
429
361
1 331
117
239
310
630
1 154
835
2 790
2 663
7 209
5 371
4 395
Other Assets
0
0
0
0
0
0
0
0
0
450
450
450
500
500
500
500
450
450
0
0
0
0
0
0
Total Assets
69 786
N/A
74 882
+7%
84 531
+13%
102 170
+21%
127 833
+25%
123 177
-4%
130 629
+6%
122 925
-6%
159 959
+30%
171 029
+7%
185 722
+9%
189 235
+2%
200 386
+6%
227 679
+14%
233 410
+3%
238 488
+2%
251 428
+5%
257 792
+3%
287 589
+12%
291 394
+1%
291 974
+0%
310 478
+6%
292 971
-6%
302 873
+3%
Liabilities
Accounts Payable
749
397
312
712
518
1 330
1 950
1 264
4 327
4 034
4 741
4 759
7 807
11 034
4 466
7 496
10 319
5 663
6 141
3 878
5 751
5 657
4 880
5 018
Accrued Liabilities
824
911
974
1 133
1 255
1 358
1 237
1 198
1 435
2 488
2 507
2 307
2 762
2 314
2 941
3 178
2 501
3 608
4 069
4 084
3 835
1 864
7 597
9 415
Short-Term Debt
0
0
0
0
0
0
0
0
15 697
10 051
10 122
3 619
3 574
3 300
3 397
3 340
4 402
1 035
18
636
154
24 085
15 015
38 641
Current Portion of Long-Term Debt
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1 362
707
1 489
1 350
277
30
Other Current Liabilities
5 178
2 366
1 525
6 149
11 990
4 961
5 646
3 616
8 820
10 457
12 587
18 749
12 467
15 357
9 696
13 180
12 686
29 109
11 557
16 693
14 135
17 171
31 257
25 325
Total Current Liabilities
6 753
3 678
2 811
7 994
13 763
7 649
8 833
6 077
30 279
27 029
29 957
29 434
26 609
32 004
20 501
27 194
29 908
39 415
23 148
25 999
25 364
50 127
59 027
78 428
Long-Term Debt
198
195
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25 916
421
2 686
1 434
81
7
Deferred Income Tax
6 244
6 902
7 826
6 999
2 249
3 069
1 831
150
725
1 711
1 345
1 825
2 642
2 815
3 126
1 142
104
0
1 267
827
1 016
1 045
0
0
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
139
417
159
696
1 355
1 606
6 064
8 161
575
469
321
298
276
Other Liabilities
644
2 136
1 795
1 715
1 778
1 059
1 244
1 439
5 228
3 458
3 802
4 218
2 104
2 430
5 344
1 581
2 066
597
2 391
1 386
2 618
347
5 386
4 100
Total Liabilities
13 839
N/A
12 910
-7%
12 433
-4%
16 708
+34%
17 790
+6%
11 778
-34%
11 907
+1%
7 666
-36%
36 232
+373%
32 198
-11%
35 104
+9%
35 338
+1%
30 938
-12%
37 408
+21%
28 275
-24%
28 561
+1%
30 473
+7%
46 076
+51%
60 883
+32%
29 207
-52%
32 153
+10%
53 274
+66%
64 792
+22%
82 812
+28%
Equity
Common Stock
6 300
6 300
6 300
6 300
9 300
13 575
13 575
13 575
13 575
13 575
13 575
13 575
13 575
13 575
13 575
13 575
13 575
13 575
13 575
15 684
15 684
15 684
15 684
15 684
Retained Earnings
38 835
48 500
58 156
70 655
86 624
98 615
108 555
113 677
121 180
137 923
150 659
153 111
166 728
183 221
190 772
201 403
213 870
209 404
221 138
227 040
228 447
231 800
198 616
193 299
Additional Paid In Capital
11 515
11 912
11 811
11 830
13 934
9 659
9 659
9 659
9 659
1 995
1 995
1 995
1 995
2 054
2 054
2 054
2 054
339
3 415
27 387
27 348
27 238
27 238
34 100
Unrealized Security Profit/Loss
392
226
123
186
186
275
908
1 043
78
245
330
1 389
3 336
7 567
12 597
9 494
7 577
3 330
3 469
8 392
9 784
4 600
8 795
6 797
Treasury Stock
1 095
4 965
4 292
3 510
1
10 724
13 975
20 609
20 609
20 609
21 423
21 423
21 423
21 423
19 962
22 735
22 285
21 535
21 535
22 890
28 166
28 916
28 916
30 133
Other Equity
0
0
0
0
0
0
0
0
0
5 703
5 482
5 250
5 237
5 278
6 099
6 136
6 164
6 602
6 643
6 573
6 723
6 798
6 762
313
Total Equity
55 946
N/A
61 973
+11%
72 098
+16%
85 462
+19%
110 043
+29%
111 400
+1%
118 722
+7%
115 259
-3%
123 727
+7%
138 831
+12%
150 618
+8%
153 897
+2%
169 448
+10%
190 271
+12%
205 135
+8%
209 927
+2%
220 955
+5%
211 716
-4%
226 706
+7%
262 187
+16%
259 821
-1%
257 204
-1%
228 179
-11%
220 061
-4%
Total Liabilities & Equity
69 786
N/A
74 882
+7%
84 531
+13%
102 170
+21%
127 833
+25%
123 177
-4%
130 629
+6%
122 925
-6%
159 959
+30%
171 029
+7%
185 722
+9%
189 235
+2%
200 386
+6%
227 679
+14%
233 410
+3%
238 488
+2%
251 428
+5%
257 792
+3%
287 589
+12%
291 394
+1%
291 974
+0%
310 478
+6%
292 971
-6%
302 873
+3%
Shares Outstanding
Common Shares Outstanding
27
25
26
25
27
26
25
24
24
24
24
24
24
24
24
24
24
24
24
28
27
27
27
27
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett